AlbertAssadMD

Clinical Trials

• Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke Start of enrollment: 2011 Mar 01

  Terminated

  Phase 2

• A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis Start of enrollment: 2017 Feb 08

  Terminated

  Phase 2

• Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272) Start of enrollment: 2017 Nov 14

  Terminated

  Phase 2

• An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis Start of enrollment: 2012 Jul 16

  Completed

  Phase 2

• Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia Start of enrollment: 2008 Aug 20

  Terminated

  Phase 2

• A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia Start of enrollment: 2016 Sep 30

  Active, not recruiting

  Phase 2

• To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) Start of enrollment: 2021 May 27

  Active, not recruiting

  Phase 3

• To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) Start of enrollment: 2021 May 26

  Active, not recruiting

  Phase 3

• Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors Start of enrollment: 2013 Jun 01

  Completed

  Phase 1, Phase 2

• Join now to see all